GlaxoSmithkline Consumer Healthcare (Delisted) MD, chairman, board of directors and AGM

BSE: 500676

Formerly Smithkline Beecham Consumer Healthcare

Last traded ₹10,732.60 on 15 Apr 2020

Delisted on 24 Jun 2021.

GlaxoSmithkline Consumer Healthcare AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.GlaxoSmithkline Consumer Healthcare share news and announcements

Postal ballot, 6 Oct 2019

The company's voting result (opens in a new tab)

  1. Approval for Related Party Transactions
    OrdinaryPromoters have an interest in it
    63.66% for36.34% against

    Against: promoters 0.00% · institutions 44.74% · other public 0.20%

    Turnout: all 6.81% · promoters 0.00% · institutions 48.65% · other public 7.94%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 2 Aug 2019, 8 resolutions

Present: 2 promoters and 35 others.The company's voting result (opens in a new tab)

  1. To consider and adopt the audited financial statements of the Company for the year ended March 31, 2019
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 83.71% · promoters 100.00% · institutions 86.93% · other public 8.99%

  2. To declare dividend for the year ended March 31, 2019 of Rs. 105/-per equity shares, as recommended by the Board of Directors
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 83.72% · promoters 100.00% · institutions 86.99% · other public 9.02%

  3. To consider and approve re-appointment of Ms. Sangeeta Talwar (DIN : 00062478) Independent Director of the Company for another term with effect from August 02, 2019 till the conclusion of sixty third Annual General MeetingMoreLess
    Special
    99.97% for0.03% against

    Against: promoters 0.00% · institutions 0.16% · other public 0.51%

    Turnout: all 82.80% · promoters 100.00% · institutions 78.82% · other public 9.02%

  4. To consider and approve appointment of Mr. P. Dwarakanath (DIN: 00231713) Non- Executive Director of the Company with effect from July 01, 2018
    Ordinary
    99.86% for0.14% against

    Against: promoters 0.00% · institutions 1.18% · other public 0.51%

    Turnout: all 82.97% · promoters 100.00% · institutions 80.32% · other public 9.02%

  5. To consider and approve appointment of Mr. S. Madhavan (DIN : 0641889) Independent Director of the Company for the period of 3 years i.e September 25, 2018 to September 24, 2021
    Ordinary
    99.92% for0.08% against

    Against: promoters 0.00% · institutions 0.70% · other public 0.06%

    Turnout: all 84.00% · promoters 100.00% · institutions 90.26% · other public 9.02%

  6. To consider and approve appointment of Mr. P.V. Bhide ( DIN : 03304262) Independent Director of the Company for a period of 3 years i.e May 10, 2019 to May 09, 2022
    Ordinary
    99.88% for0.12% against

    Against: promoters 0.00% · institutions 1.00% · other public 0.56%

    Turnout: all 82.80% · promoters 100.00% · institutions 78.82% · other public 9.02%

  7. To approve re- appointment, remuneration and terms of re- appointment of Mr. Anup Dhingra (DIN: 07602670) as Director - Operations with effect from August 02, 2019 till the conclusion of Sixty third Annual General MeetingMoreLess
    Ordinary
    99.88% for0.12% against

    Against: promoters 0.00% · institutions 1.02% · other public 0.50%

    Turnout: all 82.80% · promoters 100.00% · institutions 78.82% · other public 9.02%

  8. To approve re - appoinment, remuneration and terms of re - appointment of Mr. Vivek Anand (DIN: 06891864) as director - Finance, CEO with effect from August 02, 2019 till the conclusion of Sixty third Annual General MeetingMoreLess
    Ordinary
    99.88% for0.12% against

    Against: promoters 0.00% · institutions 1.02% · other public 0.50%

    Turnout: all 82.80% · promoters 100.00% · institutions 78.82% · other public 9.02%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Meeting called by the tribunal, 1 Jun 2019, 1 resolution

Present: 2 promoters and 29 others.The company's voting result (opens in a new tab)

  1. Approval of the scheme of amalgamation among GlaxoSmithKline Consumer Healthcare Limited and Hindustan Unilever Limited and their respective shareholders and creditors under sections 230 to 232 and other applicable provisions of the Companies Act,2013 and other matters incidental theretoMoreLess
    Special
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.70%

    Turnout: all 83.25% · promoters 100.00% · institutions 80.42% · other public 9.45%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 12 Apr 2019, 3 resolutions

Present: 0 promoters and 0 others.The company's voting result (opens in a new tab)

  1. Revision in the terms of payment of remuneration to Mr. Navneet Saluja, Managing Director (DIN: 02183350)
    Ordinary
    99.72% for0.28% against

    Against: promoters 0.00% · institutions 3.67% · other public 1.00%

    Turnout: all 79.49% · promoters 100.00% · institutions 49.25% · other public 7.60%

  2. Revision in the terms of payment of remuneration to Mr. Anup Dhingra, Director – Operations (DIN: 07602670)
    Ordinary
    99.72% for0.28% against

    Against: promoters 0.00% · institutions 3.67% · other public 1.00%

    Turnout: all 79.49% · promoters 100.00% · institutions 49.25% · other public 7.60%

  3. Revision in the terms of payment of remuneration to Mr. Vivek Anand, Director Finance and Chief Financial Officer (DIN: 06891864)
    Ordinary
    99.72% for0.28% against

    Against: promoters 0.00% · institutions 3.67% · other public 1.00%

    Turnout: all 79.49% · promoters 100.00% · institutions 49.25% · other public 7.60%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 21 Dec 2018, 3 resolutions

Present: 0 promoters and 0 others.The company's voting result (opens in a new tab)

  1. Revision in the terms of payment of remuneration to Mr. Navneet Saluja, Managing Director (DIN: 02183350)
    Ordinary
    99.71% for0.29% against

    Against: promoters 0.00% · institutions 3.01% · other public 0.92%

    Turnout: all 80.90% · promoters 100.00% · institutions 59.16% · other public 7.43%

  2. Revision in the terms of payment of remuneration to Mr. Vivek Anand, Director Finance and Chief Financial Officer (DIN: 06891864)
    Ordinary
    99.71% for0.29% against

    Against: promoters 0.00% · institutions 3.01% · other public 0.94%

    Turnout: all 80.90% · promoters 100.00% · institutions 59.16% · other public 7.43%

  3. Revision in the terms of payment of remuneration to Mr. Anup Dhingra, Director – Operations (DIN: 07602670)
    Ordinary
    99.71% for0.29% against

    Against: promoters 0.00% · institutions 3.01% · other public 0.91%

    Turnout: all 80.90% · promoters 100.00% · institutions 59.16% · other public 7.43%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 8 Aug 2018, 5 resolutions

Present: 2 promoters and 48 others.The company's voting result (opens in a new tab)

  1. To consider and adopt the Audited Financial Statements of the Company for the year ended March 31, 2018 including Audited Balance Sheet as at March 31, 2018 and the Statement of Profit and Loss for the year ended March 31, 2018 together with the Reports of the Directors and AuditorsMoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.08%

    Turnout: all 83.48% · promoters 100.00% · institutions 79.39% · other public 6.79%

  2. To declare Dividend for the year ended March 31, 2018 of Rs. 75/- per equity share, as recommended by the Board of Directors.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 83.59% · promoters 100.00% · institutions 80.29% · other public 6.78%

  3. To ratify the appointment of Statutory Auditors.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.02%

    Turnout: all 83.59% · promoters 100.00% · institutions 80.29% · other public 6.78%

  4. To approve the appointment and remuneration of Mr. Navneet Saluja as Managing Director
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.09%

    Turnout: all 83.59% · promoters 100.00% · institutions 80.29% · other public 6.78%

  5. To approve and adopt the new Articles of Association
    Special
    96.93% for3.07% against

    Against: promoters 0.00% · institutions 34.30% · other public 0.74%

    Turnout: all 80.66% · promoters 100.00% · institutions 57.05% · other public 6.78%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

How mutual funds voted

Fund houses must disclose how they vote at every meeting of a company they hold.

Mutual fund votes, meeting of 6 Oct 2019, 11 fund houses

  • Approval for Related Party Transactions
    Against Franklin Templeton Mutual Fund, HSBC Mutual Fund
    • Franklin Templeton Mutual FundA vote AGAINST this resolution is warranted due to lack of further clarification on some of the transactions (i.e. land purchase and lease payment in Sonepat) and because the proposal affects shareholders' ability to review and vote on these transactions going forward.
    • HSBC Mutual FundA vote AGAINST this resolution is warranted due to lack of further clarification on some of the transactions (i.e. land purchase and lease payment in Sonepat) and because the proposal affects shareholders'ability to review and vote on these transactions going forward.
    8 for2 against

    1 abstained

Mutual fund votes, meeting of 2 Aug 2019, 11 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • To consider and adopt the audited financial statements of the Company for the year ended March 31, 2019
    10 for0 against
  • To declare dividend for the year ended March 31, 2019 of Rs. 105/-per equity shares, as recommended by the Board of Directors
    10 for0 against
  • To consider and approve re-appointment of Ms. Sangeeta Talwar (DIN : 00062478) Independent Director of the Company for another term with effect from August 02, 2019 till the conclusion of sixty third Annual General MeetingMoreLess
    10 for0 against

    1 abstained

  • To consider and approve appointment of Mr. P. Dwarakanath (DIN: 00231713) Non- Executive Director of the Company with effect from July 01, 2018
    11 for0 against
  • To consider and approve appointment of Mr. S. Madhavan (DIN : 0641889) Independent Director of the Company for the period of 3 years i.e September 25, 2018 to September 24, 2021
    9 for0 against

    1 abstained

  • To consider and approve appointment of Mr. P.V. Bhide ( DIN : 03304262) Independent Director of the Company for a period of 3 years i.e May 10, 2019 to May 09, 2022
    9 for0 against

    1 abstained

  • To approve re- appointment, remuneration and terms of re- appointment of Mr. Anup Dhingra (DIN: 07602670) as Director - Operations with effect from August 02, 2019 till the conclusion of Sixty third Annual General MeetingMoreLess
    10 for0 against

    1 abstained

  • To approve re - appoinment, remuneration and terms of re - appointment of Mr. Vivek Anand (DIN: 06891864) as director - Finance, CEO with effect from August 02, 2019 till the conclusion of Sixty third Annual General MeetingMoreLess
    8 for0 against

    1 abstained

5 proposals not matched to one resolution
  • Item 1, as a fund house numbered it
    1 for0 against
  • Item 2, as a fund house numbered it
    1 for0 against
  • Item 5, as a fund house numbered it
    1 for0 against
  • Item 6, as a fund house numbered it
    1 for0 against
  • Item 8, as a fund house numbered it
    1 for0 against
6 earlier meetings

Mutual fund votes, meeting of 1 Jun 2019, 12 fund houses

  • Approval of the scheme of amalgamation among GlaxoSmithKline Consumer Healthcare Limited and Hindustan Unilever Limited and their respective shareholders and creditors under sections 230 to 232 and other applicable provisions of the Companies Act,2013 and other matters incidental theretoMoreLess
    12 for0 against

Mutual fund votes, meeting of 12 Apr 2019, 13 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • Revision in the terms of payment of remuneration to Mr. Navneet Saluja, Managing Director (DIN: 02183350)
    11 for0 against

    2 abstained

  • Revision in the terms of payment of remuneration to Mr. Anup Dhingra, Director – Operations (DIN: 07602670)
    11 for0 against

    2 abstained

  • Revision in the terms of payment of remuneration to Mr. Vivek Anand, Director Finance and Chief Financial Officer (DIN: 06891864)
    10 for0 against

    2 abstained

1 proposal not matched to one resolution
  • Item 3, as a fund house numbered it
    1 for0 against

Mutual fund votes, meeting of 21 Dec 2018, 11 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • Revision in the terms of payment of remuneration to Mr. Navneet Saluja, Managing Director (DIN: 02183350)
    Against Baroda BNP Paribas Mutual Fund
    • Baroda BNP Paribas Mutual FundConsidering the approval of salary by AGM recently in the month of August-2018, there is no need for increase in payment for the year. No rational is given for the same
    9 for1 against

    1 abstained

  • Revision in the terms of payment of remuneration to Mr. Vivek Anand, Director Finance and Chief Financial Officer (DIN: 06891864)
    Against Baroda BNP Paribas Mutual Fund
    • Baroda BNP Paribas Mutual FundThere was no agenda of salary in AGM recently in the month of August-2018. No rational is given for the same
    8 for1 against

    1 abstained

  • Revision in the terms of payment of remuneration to Mr. Anup Dhingra, Director – Operations (DIN: 07602670)
    Against Baroda BNP Paribas Mutual Fund
    • Baroda BNP Paribas Mutual FundThere was no agenda of salary in AGM recently in the month of August-2018. No rational is given for the same
    9 for1 against

    1 abstained

1 proposal not matched to one resolution
  • Item 2, as a fund house numbered it
    1 for0 against

Mutual fund votes, meeting of 8 Aug 2018, 10 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • To consider and adopt the Audited Financial Statements of the Company for the year ended March 31, 2018 including Audited Balance Sheet as at March 31, 2018 and the Statement of Profit and Loss for the year ended March 31, 2018 together with the Reports of the Directors and AuditorsMoreLess
    6 for0 against

    1 abstained

  • To declare Dividend for the year ended March 31, 2018 of Rs. 75/- per equity share, as recommended by the Board of Directors.
    9 for0 against
  • To ratify the appointment of Statutory Auditors.
    8 for0 against
  • To approve the appointment and remuneration of Mr. Navneet Saluja as Managing Director
    10 for0 against
  • To approve and adopt the new Articles of Association
    Against 360 One Mutual Fund, Franklin Templeton Mutual Fund, Mahindra Manulife Mutual Fund, SBI Mutual Fund
    • 360 One Mutual Fund, Mahindra Manulife Mutual Fund, SBI Mutual FundThe company is seeking approval of shareholders for the adoption of the new set of AoA by aligning it with the provisions of Companies Act, 2013. The company has not uploaded the revised AoA on its website. Shareholders will be required to visit the company’s premises to understand the alterations and review the revised AoA.
    • Franklin Templeton Mutual FundA vote AGAINST this resolution is warranted due to lack of information.
    3 for4 against

    1 abstained

8 proposals not matched to one resolution
  • Item 1, as a fund house numbered it
    1 for0 against
  • Item 2, as a fund house numbered it
    1 for0 against
  • Item 3, as a fund house numbered it
    1 for0 against
  • Item 5, as a fund house numbered it
    Against Taurus Mutual Fund
    • Taurus Mutual FundThe company is seeking approval of shareholders for the adoption of the new set of AoA by aligning it with the provisions of Companies Act, 2013. The company has not uploaded the revised AoA on its website. Shareholders will be required to visit the company’s premises to understand the alterations and review the revised AoA.
    0 for1 against
  • Accept Financial Statements and Statutory Reports
    1 for0 against
  • Adoption of Financial Statements of the Company
    1 for0 against
  • Approve Deloitte Haskins & Sells LLP, Chartered Accountants as Auditors and Authorize Board to Fix Their Remuneration
    1 for0 against
  • To substitute the regulations contained in the existing AOA
    1 for0 against

Mutual fund votes, meeting of 9 Aug 2017, 4 fund houses

  • 1) Adoption of Audited Financial Statements for the year ended 31st March, 2017 and the Reports of the Directors & Auditors thereon.
    1 for0 against
  • 2) To declare Dividend.
    1 for0 against
  • 3) Appoint M/s. Deloitte Haskins & Sells LLP as Statutory Auditors and fix their remuneration.
    1 for0 against
  • 4) Appoint Mr. Anup Dhingra as an Executive Director designated as "Director - Operations" for a period of three years with effect from 1st September, 2016 and fix his remuneration.
    1 for0 against
  • Adoption of Accounts
    1 for0 against
  • Adoption of financial statements for the year ended 31 March 2017
    1 for0 against
  • Appoint Anup Dhingra (DIN: 07602670) as an Executive Director for a period of three years with effect from 1 September 2016 and fix his remuneration
    1 for0 against
  • Appoint Deloitte Haskins & Sells LLP as statutory auditors for five years and fix their remuneration
    1 for0 against
  • Appointment of Auditors
    1 for0 against
  • Appointment of Mr. Anup Dhingra as an Executive Director and fixing of his remuneration
    0 for0 against

    1 abstained

  • Declaration of dividend
    1 for0 against
  • Declare final dividend of Rs.70.0 per share (FV Rs.10.0)
    1 for0 against
  • To appoint M/s. Deloitte Haskins & Sells LLP as the Statutory Auditors of the Company & to fix their remuneration
    1 for0 against
  • To appoint Mr. Anup Dhingra (holding DIN: 07602670) as an Executive Director of the Company designated as “Director-Operations” with effect from September 1, 2016 up to the Annual General Meeting to be held in 2019 and fixation of remunerationMoreLess
    1 for0 against
  • To consider and adopt the Audited Financial Statements of the Company for the year ended March 31, 2017 including Audited Balance Sheet as at March 31, 2017 and the Statement of Profit and Loss for the year ended March 31, 2017 together with the Reports of the Directors and AuditorsMoreLess
    1 for0 against
  • To consider and approve the declaration of Dividend for the year ended March 31, 2017 of Rs.70 per equity share, as recommended by the Board of Directors.
    1 for0 against

Mutual fund votes, meeting of 5 Aug 2016, 2 fund houses

  • Accept Financial Statements and Statutory Reports
    1 for0 against
  • Appointment of Mr. Jaiboy John Phillips (holding DIN: 01417171) as a Whole-time Director of the Company designated as “Director-Operations” for a period of three years with effect from August 5, 2016 and fixation of remunerationMoreLess
    1 for0 against
  • Appointment of Mr. Vivek Anand (holding DIN: 06891864) as a Whole-time Director of the Company designated as “Director-Finance and Chief Financial Officer” for a period of three years with effect from August 5, 2016 and fixation of remunerationMoreLess
    1 for0 against
  • Approve Appointment and Remuneration of Jaiboy John Phillips as Executive Director, Director-Operations
    1 for0 against
  • Approve Appointment and Remuneration of Vivek Anand as Executive Director, Designated as Director-Finance and CFO
    1 for0 against
  • Approve Dividend Payment
    1 for0 against
  • Approve Price Waterhouse as Auditors and Authorize Board to Fix Their Remuneration
    1 for0 against
  • Elect Jaiboy John Phillips as Director
    1 for0 against
  • Elect Kunal Kashyap as Director
    1 for0 against
  • Elect Mukesh H. Butani as Director
    1 for0 against
  • Elect Naresh Dayal as Director
    1 for0 against
  • Elect P. Dwarakanath as Director
    1 for0 against
  • Elect Sangeeta Talwar as Director
    1 for0 against
  • Elect Vivek Anand as Director
    1 for0 against
  • To appoint Directors in accordance with the provisions of Section 163 of the Companies Act, 2013 and Article 97 of the Articles of Association of the Company. Notices under Section 160 of the Companies Act, 2013 have been received from Mr. Kunal Kashyap, Mr. P. Dwarakanath, Mr. Naresh Dayal, Mr. Mukesh H. Butani, Ms. Sangeeta Talwar, Mr. Jaiboy John Phillips and Mr. Vivek Anand, proposing their own candidature for the appointment as Directors of the Company.MoreLess
    1 for0 against
  • To appoint M/s. Price Waterhouse, Chartered Accountants AS Statutory Auditors of the Company and to authorise the Board of Directors to fix their remuneration
    1 for0 against
  • To consider and adopt the Audited Financial Statements of the Company for the year ended March 31, 2016 including Audited Balance Sheet as at March 31, 2016 and the Statement of Profit and Loss for the year ended March 31, 2016 together with the Reports of the Directors and AuditorsMoreLess
    1 for0 against
  • To consider and approve the decalaration of Dividend for the year ended March 31, 2016
    1 for0 against

Each fund house counted once, from its own disclosure; the reasons are its own words.